Skip to main content
Fig. 5 | Microbiome

Fig. 5

From: Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

Fig. 5

FMT-engrafting strains altered the metabolic capacity of the gut microbiome. a Bacterial metabolic pathways in the gut microbiome found to be differentially abundant between FMT and placebo recipients at week 6 (linear model, FDR adjusted q < 0.2). b Heatmap displaying UniRef90 gene families belonging to the nicotinamide adenine dinucleotide (NAD) biosynthesis from aspartate pathway that were gained (red cells) by female FMT recipients at week 6 (i.e., were not present at baseline). Placebo recipient data were included to differentiate between environmental gain (gene families likely acquired from common species within the environment) and FMT-specific gain (gene families likely acquired from a donor-engrafting species)

Back to article page